Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease

American Heart Journal

Volumn 161, Issue 1, 2011, Pages

  Alsheikh Ali, Alawi A ^a,b   Trikalinos, Thomas A ^a   Ruthazer, Robin ^a   Terrin, Norma ^a   Wong, John B ^a   Sarnak, Mark J ^a   Estes III, N A Mark ^a   Kent, David M ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 78650373862     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.09.020     Document Type: Article

References (29)

1. Weiss C.O., Boyd C.M., and Yu Q. Patterns of prevalent major chronic disease among older adults in the United States JAMA 298 2007 1160 1162 (Pubitemid 47403117)
2. Kent D.M., Alsheikh-Ali A., and Hayward R.A. Competing risk and heterogeneity of treatment effect in clinical trials Trials 9 2008 30 (Pubitemid 351832972)
3. Hayward R.A., Kent D.M., and Vijan S. Reporting clinical trial results to inform providers, payers, and consumers Health Aff (Millwood) 24 2005 1571 1581
4. Kent D.M., and Hayward R.A. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification JAMA 298 2007 1209 1212
5. Epstein A.E., DiMarco J.P., and Ellenbogen K.A. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 408
6. American Heart Association Heart disease and stroke statistics-2010 update 2010 American Heart Association Dallas, TX Available at: http://www.americanheart.org/presenter.jhtml?identifier=1200026 Last accessed July 9, 2010
7. US Renal Data System USRDS 2009 annual data report 2009 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD Available at: http://www.usrds.org/atlas.htm Last accessed July 9, 2010
8. Dries D.L., Exner D.V., and Domanski M.J. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
9. Sarnak M.J., Levey A.S., and Schoolwerth A.C. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169 (Pubitemid 37337595)
10. Owens D.K., Sanders G.D., and Heidenreich P.A. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator Am Heart J 144 2002 440 448
11. Al-Ahmad A., Rand W.M., and Manjunath G. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 38 2001 955 962 (Pubitemid 32912694)
12. Hillege H.L., Girbes A.R., and de Kam P.J. Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210 (Pubitemid 30451778)
13. Hillege H.L., Nitsch D., and Pfeffer M.A. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678 (Pubitemid 43754331)
14. Goldenberg I., Moss A.J., and McNitt S. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction Am J Cardiol 98 2006 485 490 (Pubitemid 44162874)
15. Saxon L.A., Bristow M.R., and Boehmer J. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial Circulation 114 2006 2766 2772 (Pubitemid 46018278)
16. SOLVD Investigators Studies of left ventricular dysfunction (SOLVD)-rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction Am J Cardiol 66 1990 315 322
17. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
18. SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators N Engl J Med 327 1992 685 691
19. Levey A.S., Bosch J.P., and Lewis J.B. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
20. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl 1 2002 S1 S266
21. McAlister F.A., Ezekowitz J., and Tonelli M. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 2004 1004 1009 (Pubitemid 38282853)
22. Levy W.C., Mozaffarian D., and Linker D.T. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433 (Pubitemid 43739439)
23. Mozaffarian D., Anker S.D., and Anand I. Prediction of mode of death in heart failure: the Seattle Heart Failure Model Circulation 116 2007 392 398 (Pubitemid 47196544)
24. Levy W.C., Lee K.L., and Hellkamp A.S. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
25. Turakhia M.P., Varosy P.D., and Lee K. Impact of renal function on survival in patients with implantable cardioverter-defibrillators Pacing Clin Electrophysiol 30 2007 377 384 (Pubitemid 46426556)
26. Cuculich P.S., Sanchez J.M., and Kerzner R. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death Pacing Clin Electrophysiol 30 2007 207 213 (Pubitemid 46333676)
27. Goldenberg I., Vyas A.K., and Hall W.J. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
28. Dhar R., Alsheikh-Ali A.A., and Estes N.A. III Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) Heart Rhythm 5 2008 807 813
29. Fisher L.D., and Lin D.Y. Time-dependent covariates in the Cox proportional-hazards regression model Annu Rev Public Health 20 1999 145 157